Top 10 Countries by Per Capita Healthcare R&D Expenditure

In the 2026 global R&D landscape, Switzerland once again holds the top spot for per capita medical R&D expenditure, cementing its status as the 'Silicon Valley of Life Sciences.'

• Investment Scale: Switzerland’s per capita expenditure is roughly 8 times the global average. The core engine is its dense biopharmaceutical ecosystem, anchored by global giants like Roche and Novartis.
• Comparative Analysis: While the U.S. drives innovation through a massive healthcare market, Switzerland excels through a remarkably high GDP-to-R&D conversion rate. Despite a population of only 9 million, its medical R&D output rivals that of economies with ten times its size.
• Key Facts: Switzerland boasts one of the highest densities of patent filings globally. With over 70% of R&D funding sourced from the private sector, this 'high-output, strong-incentive' model keeps the nation at the forefront of breakthroughs in oncology and gene editing.